Total Payments
$14,985
2024 Payments
$1,921
Companies
39
Transactions
318
Medicare Patients
6,711
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$14,848 (99.1%)
Education$134.02 (0.9%)
Travel$2.73 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,848 | 310 | 99.1% |
| Education | $134.02 | 7 | 0.9% |
| Travel and Lodging | $2.73 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,675 | 75 | $0 (2022) |
| Amgen Inc. | $1,760 | 32 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,176 | 21 | $0 (2024) |
| ABBVIE INC. | $998.78 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $976.36 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $944.87 | 12 | $0 (2024) |
| Lilly USA, LLC | $613.42 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $597.25 | 12 | $0 (2024) |
| PFIZER INC. | $528.15 | 11 | $0 (2021) |
| Genentech USA, Inc. | $523.19 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,921 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($344.72) |
| 2023 | $1,019 | 19 | GlaxoSmithKline, LLC. ($244.55) |
| 2022 | $1,761 | 48 | Amgen Inc. ($272.13) |
| 2021 | $1,446 | 35 | Janssen Pharmaceuticals, Inc ($288.19) |
| 2020 | $519.19 | 20 | Pfizer Inc. ($90.11) |
| 2019 | $2,405 | 53 | Janssen Pharmaceuticals, Inc ($816.55) |
| 2018 | $3,069 | 57 | Janssen Pharmaceuticals, Inc ($888.42) |
| 2017 | $2,844 | 62 | Janssen Pharmaceuticals, Inc ($534.28) |
All Payment Transactions
318 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $5.00 | General |
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $98.52 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $36.47 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.94 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $122.82 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $103.94 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 06/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $115.88 | General |
| Category: Cardiovascular | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $82.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $114.71 | General |
| Category: DIABETES | ||||||
| 04/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $129.67 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $127.25 | General |
| Category: Rare Disease | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $68.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $120.60 | General |
| Category: Immunology | ||||||
| 02/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $89.99 | General |
| Category: DIABETES | ||||||
| 02/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $115.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $95.94 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $66.56 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,621 | 7,579 | $507,776 | $300,520 |
| 2022 | 28 | 1,609 | 6,614 | $487,639 | $275,375 |
| 2021 | 25 | 1,759 | 6,299 | $528,218 | $279,399 |
| 2020 | 29 | 1,722 | 6,235 | $490,801 | $261,756 |
Total Patients
6,711
Total Services
26,727
Medicare Billing
$1.1M
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 32 | 3,060 | $72,650 | $55,816 | 76.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 131 | 1,073 | $80,475 | $50,683 | 63.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 245 | 737 | $92,125 | $50,244 | 54.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 107 | 118 | $26,550 | $17,308 | 65.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 45 | 306 | $38,250 | $16,265 | 42.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 52 | 312 | $23,400 | $13,616 | 58.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 54 | 330 | $19,800 | $13,418 | 67.8% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 51 | 95 | $17,575 | $12,173 | 69.3% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 105 | 210 | $15,750 | $10,317 | 65.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $10,595 | $8,420 | 79.5% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 45 | 108 | $10,800 | $7,203 | 66.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 56 | 89 | $12,905 | $5,184 | 40.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $9,300 | $4,596 | 49.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 59 | 59 | $5,595 | $4,473 | 79.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 110 | $7,065 | $4,357 | 61.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 62 | 66 | $9,225 | $4,273 | 46.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 48 | 74 | $10,360 | $3,237 | 31.2% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 13 | 13 | $3,162 | $3,073 | 97.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $4,698 | $2,811 | 59.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $3,080 | $2,285 | 74.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 62 | $3,100 | $2,039 | 65.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 17 | $3,210 | $1,646 | 51.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,080 | $1,440 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $2,450 | $1,413 | 57.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 23 | $1,610 | $1,040 | 64.6% |
About Dr. Scott Stringer, MD
Dr. Scott Stringer, MD is a Emergency Medicine healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720196611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Stringer, MD has received a total of $14,985 in payments from pharmaceutical and medical device companies, with $1,921 received in 2024. These payments were reported across 318 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($14,848).
As a Medicare-enrolled provider, Stringer has provided services to 6,711 Medicare beneficiaries, totaling 26,727 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine
- Location Sacramento, CA
- Active Since 08/29/2006
- Last Updated 10/27/2016
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1720196611
Products in Payments
- XARELTO (Drug) $1,607
- INVOKANA (Drug) $1,068
- JARDIANCE (Drug) $703.79
- COSENTYX (Biological) $608.57
- FARXIGA (Drug) $562.00
- Enbrel (Biological) $554.53
- RINVOQ (Biological) $457.22
- Actemra (Biological) $429.50
- XELJANZ (Drug) $422.75
- TREMFYA (Drug) $414.50
- Prolia (Biological) $401.80
- INGREZZA (Drug) $381.69
- Otezla (Drug) $340.17
- Kerendia (Drug) $327.23
- SAPHNELO (Biological) $307.91
- Humira (Biological) $241.75
- AVSOLA (Biological) $228.48
- CAMZYOS (Drug) $225.16
- KEVZARA (Drug) $225.02
- TALTZ (Drug) $209.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Sacramento
Eric Gross
Emergency Medicine — Payments: $244,685
Emergency Medicine $244,685
Dr. David Beffa, M.d, M.D
Emergency Medicine — Payments: $136,371
Emergency Medicine $136,371
Selene Castrejon, M.d, M.D
Emergency Medicine — Payments: $59,769
Emergency Medicine $59,769
Daniel Nishijima, M.d, M.D
Emergency Medicine — Payments: $41,591
Emergency Medicine $41,591
Dr. Cheryl Vance, Md, MD
Emergency Medicine — Payments: $7,732
Emergency Medicine $7,732
Dr. Bryn Mumma, M.d, M.D
Emergency Medicine — Payments: $6,002
Emergency Medicine $6,002